Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles
-
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement
-
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
-
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
-
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
-
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
-
Beyond, Inc. to Participate in Upcoming Investor Conferences
-
Electric Metals (USA) Limited Further Strengthens its Board of Directors
-
Zion Oil & Gas, Inc. Announces Start of Recompletion Operations for our MJ-01 Well in Israel
-
Lowe's Pioneers a New Era of In-Store Kitchen Design with Apple Vision Pro
-
Paul Hastings Adds Premier Restructuring and Private Credit Team, Further Strengthening Market-Leading Restructuring and Finance Platforms
-
The Seasons Games - An immersive experience at the Théâtre du Lido des Champs-Elysées in Paris
-
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
LCS Announces 2024 Chef of the Year Finalists
-
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
-
Form 8.3 - Irish Residential Properties REIT plc
-
Genflow Biosciences PLC Announces Notice of AGM
-
Stillwater Critical Minerals Appoints Glencore’s Bradley Adamson to its Board of Directors
-
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
-
GameSquare Sells Non-Core Content Management Software and PR Media Distribution Assets
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Report on transactions of executives and related parties in ROCKWOOL A/S shares
-
Hi-Tech Pharmaceuticals: Increases Capacity on Precision Protein™ Hydrolyzed Whey
-
Eagle Royalties Appoints New Chief Financial Officer
-
Zedge To Report Third Fiscal Quarter 2024 Results
-
Procure Disaster Recovery Strategy ETF (NASDAQ:FIXT) Up 35% Since Launch
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
-
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
-
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
-
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities
-
First Fully Electronic F-TIIE Swap Trade Executed on the Bloomberg SEF
-
Bridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing Strategy
-
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
-
NorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
DIGITIMES Asia: Nvidia's Jensen Huang discloses next-gen Ruben platform and physical AI vision at NTU keynote
-
Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting
-
Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family
-
Molecular Templates, Inc. Provides Interim Update
-
Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Aptevo Participating in the BIO International Convention
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
V2X announces successful repricing and extension of Term Loan
